SCHEMBL21115906

SCHEMBL21115906

c1ccc2cc3cc(-c4ccc5cc6cc7ccccc7cc6cc5c4)ccc3cc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.61
ESR2 Q92731 7/20 0.61
ALOX5 P09917 1/20 0.58
HSD17B1 P14061 2/20 0.56
HSD17B2 P37059 2/20 0.56
ALDH1A1 P00352 2/20 0.55
CYP3A4 P08684 2/20 0.55
ALOX15 P16050 1/20 0.55
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
HBB P68871 1/20 0.55
HIF1A Q16665 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
GSTP1 P09211 1/20 0.54
CYP17A1 P05093 1/20 0.52
CYP19A1 P11511 1/20 0.52
CYP11B1 P15538 1/20 0.52
CYP11B2 P19099 1/20 0.52
CA1 P00915 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4312882 1.00 ESR1 (0.61) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL4620954 1.00 ESR1 (0.61) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL14994162 0.97 ESR1 (0.65) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL30177479 0.97 ESR1 (0.65) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL3424690 0.97 ESR1 (0.65) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL15842052 0.97 ESR1 (0.65) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL1527556 0.92 ESR1 (0.64) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL30177515 0.92 ESR1 (0.64) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL1310968 0.92 ESR1 (0.64) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL17443014 0.92 ESR1 (0.64) ESR1ESR2ALOX5HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696685-B2 Polyketides, methods of use and preparation UNIVERSITEIT LEIDEN (NL) 2020-06-30 US disclosed
US-20190194217-A1 Polyketides, Methods of Use and Preparation UNIVERSITEIT LEIDEN (NL) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10696685-B2 Polyketides, methods of use and preparation COASY, DHPS, PHYKPL ESR1 4706/4885ESR2 4223/4885ALOX5 2096/4885
US-20190194217-A1 Polyketides, Methods of Use and Preparation COASY, DHPS, PHYKPL ESR1 4706/4885ESR2 4223/4885ALOX5 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.